⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2026Open Access

Development of bispecific nanobody-derived CARs targeting b-cell leukemia markers: CD19, CD20, and CD22

João Marques Martín Bonamino Andréa Maranhão Carla Fernandes Maurício Tilburg

View Full Paper

Ask AI

Bookmark

Share

Key Points

To develop bispecific nanobody-derived CARs targeting B-cell leukemia markers CD19, CD20, and CD22.
Development of bispecific nanobody-derived CARs
Targeting specific leukemia markers
Presentation at an international symposium
New CAR designs implemented for CD19, CD20, and CD22
Potential improvements in targeting B-cell leukemia
Presented findings at a significant immunobiological event

Implication

International Symposium on Immunobiologicals presents developments in CAR therapies for B-cell leukemia markers.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Marques et al. (2026) studied this question.

synapsesocial.com/papers/69fece83b9154b0b82875dff https://doi.org/10.35259/isi.2026_76197

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Generation of anti-GD2 CAR-T cellsOriginal Research · 2026
2Discovery of a novel anti-IL7Rα antibody with translational potential for pediatric leukemia treatmentOriginal Research · 2026
3Abstract 36: The discovery of a novel CD19xCD22 dual-targeting CAR for the development of an IPSC-derived cell therapy2024
4Development of targeted immunomodulatory VLPs to enhance antigen presentation and potentiate the antitumor immune responseOriginal Research · 2026
5Preclinical Development of Bispecific Chimeric Antigen Receptor Targeting Both CD19 and CD22Clinical Trial · 2015 · 21 citations

Development of an antibody-drug conjugate (ADC) platform for cancer therapy2026
Generation of CAR-NK92mi cells as an off-the-shelf approach using nonviral minimized2026
Functional aplication of the iCasp9 suicide gene system as a safety mechanism for CAR-T Cells2026